共 50 条
Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer Immunotherapy
被引:31
|作者:
Zhu, Huang
[1
]
Lai, Yi-Shin
[1
]
Li, Ye
[1
]
Blum, Robert H.
[1
]
Kaufman, Dan S.
[1
]
机构:
[1] Univ Calif San Diego, Dept Med, Div Regenerat Med, San Diego, CA 92103 USA
来源:
关键词:
Cancer immunotherapy;
Adoptive cell therapy;
Human pluripotent stem cell;
T cell;
Natural Killer cell;
Natural Killer T cell;
NATURAL-KILLER-CELLS;
CHIMERIC ANTIGEN RECEPTORS;
UMBILICAL-CORD BLOOD;
TUMOR-INFILTRATING LYMPHOCYTES;
ACUTE MYELOID-LEUKEMIA;
T-CELLS;
HEMATOPOIETIC STEM;
NK CELLS;
IN-VIVO;
ADOPTIVE TRANSFER;
D O I:
10.1002/stem.2754
中图分类号:
Q813 [细胞工程];
学科分类号:
摘要:
Human pluripotent stem cells (PSCs) provide a promising resource to produce immune cells for adoptive cellular immunotherapy to better treat and potentially cure otherwise lethal cancers. Cytotoxic T cells and natural killer (NK) cells can now be routinely produced from human PSCs. These PSC-derived lymphocytes have phenotype and function similar to primary lymphocytes isolated from peripheral blood. PSC-derived T and NK cells have advantages compared with primary immune cells, as they can be precisely engineered to introduce improved anti-tumor activity and produced in essentially unlimited numbers.
引用
收藏
页码:134 / 145
页数:12
相关论文